Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1740135A reveals a cost-effective hydrolysis route for 2,5-dihalogeno benzoic acid, offering high purity and simplified supply chains for pharma intermediates.
Patent CN112142632A reveals a solvent-free synthesis route for 3,7-dimethyl-3-acetylmercapto-6-octenal, offering significant cost reduction and scalable manufacturing for the flavor and fragrance industry.
Patent CN115073399A reveals a low-cost bifunctional catalyst for high-yield chiral beta-butyrolactone production, offering significant supply chain advantages.
Patent CN102612507A reveals a diimine hydrogenation process for artemisinin intermediates, offering cost reduction and high stereoselectivity for pharmaceutical manufacturing.
Patent CN111362782B reveals a greener route to m-trifluoromethylphenol using recyclable ionic liquids, offering safer conditions and reduced waste for pharmaceutical intermediates.
Patent CN106748662B reveals a high-yield synthetic route for Oxyresveratrol, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101384564A details a high-yield route for BTG-1675A, an antidepressant intermediate, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN114805177A details a green synthesis route for saxagliptin intermediates using di-tert-butyl dicarbonate, offering significant cost reduction in API manufacturing and scalable production.
Novel visible-light synthesis of fluoroalkyl indolines using Eosin Y. Green chemistry, mild conditions, high yield for pharmaceutical intermediates.
Novel Dabrafenib preparation method offers mild conditions and high selectivity. Reliable supplier for scalable pharmaceutical intermediates with cost-effective production.
Novel copper-catalyzed method for Linagliptin intermediate ensures high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN111138345A reveals a solvent-free iron-catalyzed route for polysubstituted pyridines, offering significant cost reduction and scalability for API manufacturing.
Patent CN116969987A reveals green chitosan-copper catalysis for quinoline silylation. Achieve cost reduction in pharmaceutical intermediates manufacturing with recyclable systems.
Patent CN113105459B details electrochemical synthesis of antitumor triazolopyrimidines. Offers green chemistry advantages for pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN101684077B details a cost-effective route for N-acyl-biphenylalanine using biphenylcarboxaldehyde, offering significant supply chain advantages for API manufacturing.
Patent CN115594648B introduces mild photocatalytic alkylation. Delivers high purity and yield. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN107011239A reveals water-based Pd-catalyzed synthesis. Offers high yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102643246A details a novel one-step synthesis of chiral 2-carbonyl oxazoline using zinc chloride, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN110128341A reveals high-yield chiral cyclopropane synthesis. Achieve cost reduction in chiral ligand manufacturing with scalable supply.
Patent CN107935902B reveals a one-step decarboxylative coupling for Vonoprazan intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.